HTGC News: Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®
Thu, Feb 2, 4:02 PM
This HTGC news release, entitled "Provention Bio Announces Closing of Second Tranche with Hercules Capital to Support U.S. Commercial Launch of TZIELD®" was released Thu, Feb 2, 4:02 PM through PR Newswire.